Media

Media

84th Annual Meeting of the ATA

The Latest Thyroid News

  • 38th ETA Annual Meeting 38th ETA Annual Meeting, Santiago, Spain, 6th-10th September 2014  ETA Abstract submission online registration portal is now open: www.eta2014.com   Abstract submission closes 4/11/2014
  • IDD Newsletter IDD February 2014 Newsletter (PDF File, 1.68 MB)
  • VideoEndocrinology™ Call for Videos Launching Spring 2014 Thyroid, the preeminent journal in the field covering research and practice, and the official journal of the American Thyroid Association, has expanded to include an innovative video component, VideoEndocrinology™ (VE). Read More…
  • VideoEndocrinology™ Call for Videos Launching Spring 2014 Thyroid, the preeminent journal in the field covering research and practice, and the official journal of the American Thyroid Association, has expanded to include an innovative video component, VideoEndocrinology™ (VE). VE Editor-in-Chief Gerard M. Doherty, MD, invites you to submit your videos to this new, high-quality peer-reviewed videojournal delivering cutting-edge surgical and diagnostic imaging procedures covering thyroid, parathyroid, pancreatic, pituitary, and adrenal tumors and diseases with minimally invasive, robotic, and open surgical techniques ...
  • New Guidelines from ATA Published in Thyroid Journal American Thyroid Association Guide to Investigating Thyroid Hormone Economy and Action in Rodent and Cell Models : Report of the American Thyroid Association Task Force on Approaches and Strategies to Investigate Thyroid Hormone Economy and Action now available in the January issue of THYROID
  • NYTimes: Thyroid Supplements With a Kick Researchers have found that nine of 10 popular thyroid-boosting products sold online contained hormones that should only be dispensed by prescription. Read more…
  • Claim CME Credits CLAIM CME CREDITS FROM THE 83rd MEETING
  • FDA approves sorafenib for thyroid carcinoma From the American Thyroid Association: In collaboration with the Food and Drug Administration (FDA), and as a service to our members, ATA will provide updates on recent FDA approvals and other important FDA actions (e.g., updated safety information, new prescribing information) pertaining to therapies for cancer patients. Read More…
More